Not Applicable.
Not Applicable.
This invention relates generally to the field of administering medical chemicals, such as medical treatment, vaccines, tranquilizer, and other similar chemicals to soft tissue of unrestrained animals or sometimes in extreme cases humans.
Typical non-lethal remote delivery systems and methods capable of penetrating the skin of the targeted animal available to-date comprise a frangible projectile having a hollow tip containing a chemical encapsulated in a capsule, or a special projectile with an embedded syringe preloaded with the chemical. In some instances, a dart may be used to deliver the chemicals.
The remote delivery systems available to-date are also typically dangerous to the targeted animal, complicated, and expensive to manufacture.
The payload of remote delivery systems available to-date is typically not adaptable and cannot be configured in-situ, such as on a range, in a forest or similar situations.
In accordance with an embodiment of the instant remote medical chemicals delivery system, there is disclosed a pellet having convex shaped front portion and a concave shaped rear portion, said convex shaped front portion including a plurality of radially displaced surface slots, said concave shaped rear portion having a plurality of radially displaced surface ribs that match and can be frictionally attached to said convex portion's radially displaced slots, and said bullet shaped pellet being constructed of a combination of disrupting compounds along with appropriate binders and other compounds that may be required that are pressed together under high pressure to produce a rigid mass capable of being propelled at high speeds to pierce the skin of an animal, or a person, where the compounds can be dissolved when contacting the internal liquid portion of said animal or person, that can be delivered by discharging from an air rifle or pistol.
In accordance with another embodiment of the instant remote medical chemicals delivery system, there is disclosed a pellet configured of a plurality of linearly stacked bullet shaped pellets enabling field configuration of the payload enabling adapting the payload to the requirements of the situation at the time of usage.
The features and advantages of described in this brief summary are not to be interpreted as all-inclusive. Additional features and advantages will be apparent to a person of ordinary skills in the art in view of the specification, drawings and claims provided in the instant application.
The drawings constitute a part of this specification and include exemplary embodiments to the instant invention, which may be embodied in various forms. It is to be understood that in some instances various aspects of the instant embodiments may be shown exaggerated or enlarged to facilitate an understanding of the invention.
Detailed descriptions of the preferred embodiment are provided herein. It is to be understood, however, that the present invention may be embodied in various forms. Therefore, specific details disclosed herein are not to be interpreted as limiting, but rather as a basis for the claims and as a representative basis for teaching one skilled in the art to employ the present invention in virtually any appropriately detailed system, structure or manner.
Referring now to
Each pellet 100 is composed of chemical compounds that are compressed within a mold under high pressure to create the resulting bullet shape 100. The pressing and forming operation are similar to that of making traditional pills that are currently used in all types of pharmacological products as a means to orally ingest drug related compounds. In the case of the pellets 100 of the present invention, the pellet is propelled by a standard air rifle, gun, or pistol. The pellet 100 enters under the skin of the targeted animal or person and in doing so, comes into contact with the target's body liquids in the form of blood or other fluids which act to break down the pellet to allow the chemical ingredients of the pellet to enter the blood stream of the animal or person.
Pellets disclosed in the preferred embodiments herein are designed for discharge from a conventional off the shelf air rifle or pistol. An alternate title for these pellets is Medicated Air Gun Implant Compounds (MAGIC). The MAGIC pellets comprise a new innovation in delivering therapeutic or immobilizing drugs to animals with possible applications to humans in military or law enforcement. These MAGIC pellets are coded using color code and/or a symbol to indicate the active ingredient of each pellet and to enable the user to combine chemicals for the efficient dose. They are stackable to adjust the amount of dosage of each tranquilizing chemical or compound. The rate of dissolution after skin penetration is controlled by the incorporation of disrupting compounds along with the appropriate binders and other chemicals. The disrupting compounds, binders and other chemicals are infused in each color-coded pellet for effective use and dosage.
In the claims, the word ‘comprising’ does not exclude the presence of other elements or steps then those listed in a claim. Furthermore, the terms “a” or “an,” as used herein, are defined as “one, or more than one.” Also, the use of introductory phrases such as “at least one” and “one or more” in the claims should not be construed to imply that the introduction of another claim element by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim element to inventions containing only one such element, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an.” The same holds true for the use of definite articles. Unless stated otherwise, terms such as “first” and “second” are arbitrarily used to distinguish between the elements such terms describe. Thus, these terms are not necessarily intended to indicate temporal or other prioritization of such elements. The mere fact that certain measures are recited in mutually different claims does not indicate that a combination of these measures cannot be used to advantage.
This application is a continuation-in-part of the U.S. application Ser. No. 15/983,819 filed Nov. 11, 2018, the entire content of which is incorporated herein by reference for continuity of disclosure.
Number | Name | Date | Kind |
---|---|---|---|
4326524 | Drake, Jr | Apr 1982 | A |
4664664 | Drake, Jr. | May 1987 | A |
5648637 | Clark, III | Jul 1997 | A |
6375971 | Hansen | Apr 2002 | B1 |
8250987 | Morley | Aug 2012 | B1 |
20060254453 | Leal | Nov 2006 | A1 |
20070006769 | Dodson | Jan 2007 | A1 |
20080196616 | Cziglenyi | Aug 2008 | A1 |
20120234198 | Carmel | Sep 2012 | A1 |
20130087063 | Halter | Apr 2013 | A1 |
20140261042 | Imhoff | Sep 2014 | A1 |
Number | Date | Country | |
---|---|---|---|
20220183985 A1 | Jun 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15983819 | Nov 2018 | US |
Child | 17652931 | US |